Unfortunately ICI 216,140 (Cat. No. 0823) was withdrawn from sale in May. 2011 for commercial reasons.
To view previous batch information for ICI 216,140 (Cat. No. 0823) please follow the links below:
Certificate of Analysis / Safety Data Sheet
Keywords: Potent Bombesin/Gastrin releasing peptide antagonists GRP-Preferring Receptors BB1BB2 BB3 Gastrin-Releasing Peptide-Preferring NMB-Preferring Neuromedin B-Preferring Bombesin ICI216140 AstraZeneca
Find multiple products by catalog number
New Products in this Area
Reverse analog of BradykininTASP 0390325
Potent and selective V1B receptor antagonist; orally bioavailableML 233
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorption
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.